Calprotectin Testing
Speaker:
KT Park, MD, MS
Contact Hours:
1.0
Date:
May 23, 2025 - May 31, 2027
Description:
Non-invasive monitoring of IBD in the future of clinical management. Calprotectin is the most evidenced-based method to follow patient’s mucosal-level inflammation. It is also the emerging standard of care to screen patients prior to endoscopic and colonoscopic evaluation to more precisely determine the pre-test probability for intestinal inflammation.
Learning Objectives:
- To understand the clinical utility of fecal calprotectin as a pretest indicator for IBD before a formal endoscopic and colonoscopic evaluation.
- To globally comprehend the cost-savings associated with the quantitative fecal calprotectin testing.
- To understand 3 specific clinical scenarios where fecal calprotectin is of high value and utility in IBD.